Back to Agenda
Assessment Methods and Analytics to Ensure Data Capture from Heterogeneous Populations
Session Chair(s)
Sonya Eremenco, MA
Executive Director, PRO Consortium, Critical Path Institute, United States
This session will present an overview of the challenges with assessment methods and analytics in heterogeneous populations with case studies focusing on dermatology assessments in people of color and on methods to address heterogeneity in rare disease populations.
Learning Objective : Identify the challenges that heterogeneity poses in clinical trial research; Describe assessment methods to address phenotypic heterogeneity to improve accurate data capture; Discuss analytic methods to address heterogenous manifestations of signs, symptoms, and impacts, which are a challenge in rare diseases.
Speaker(s)
Alexandra Kalpadakis, PHD, MSC
Scientific Advisor, Signant Health, United Kingdom
The Importance of Accounting for Diversity When Training Clinicians to Apply Dermatological Rating Scales in Clinical Trials
P. K. Tandon, PHD
Senior Vice President, Biometrics and Development Strategy, Ultragenyx Pharmaceutical, United States
Multi-Domain Responder Index: A Novel Analysis Tool to Capture Broad Clinical Benefit in Heterogeneous Complex Rare Diseases
Have an account?